University of Connecticut Health Center - Know Better Care

Profiles Research Networking Software

William B White MD
Title Professor
Institution UConn Health Center
Department Medicine
Address MC 3940
263 Farmington Avenue
Farmington, CT 06030
Telephone 860-679-2104
Fax 860-679-1250
Email
Other Positions
Title Chief
Institution UConn Health Center
Department Calhoun Cardiology Center
Division Hypertension and Clinical Pharmacology
Narrative
Dr. White received his medical degree from the Medical College of Georgia. He completed his residency at the University of Connecticut School of Medicine and a fellowship at the University of Bergen, Norway. Dr. White is the author of 300 publications in peer-reviewed journals and book chapters in the area of clinical hypertension, pharmacology, and vascular diseases. He is also author of three medical textbooks in hypertension and ambulatory blood pressure monitoring, editor of the journal Blood Pressure Monitoring and a member of eight editorial boards for cardiovascular journals.
Publications
1. Weber MA, Schiffrin EL, White WB, Mann S, Lindholm LH, Kenerson JG, Flack JM, Carter BL, Materson BJ, Ram CV, Cohen DL, Cadet JC, Jean-Charles RR, Taler S, Kountz D, Townsend R, Chalmers J, Ramirez AJ, Bakris GL, Wang J, Schutte AE, Bisognano JD, Touyz RM, Sica D, Harrap SB. Clinical practice guidelines for the management of hypertension in the community a statement by the american society of hypertension and the international society of hypertension. J Hypertens. 2014 Jan; 32(1):3-15.
  View in: PubMed
 
2. Weber MA, Schiffrin EL, White WB, Mann S, Lindholm LH, Kenerson JG, Flack JM, Carter BL, Materson BJ, Ram CV, Cohen DL, Cadet JC, Jean-Charles RR, Taler S, Kountz D, Townsend RR, Chalmers J, Ramirez AJ, Bakris GL, Wang J, Schutte AE, Bisognano JD, Touyz RM, Sica D, Harrap SB. Clinical practice guidelines for the management of hypertension in the community: a statement by the american society of hypertension and the international society of hypertension. J Clin Hypertens (Greenwich). 2014 Jan; 16(1):14-26.
  View in: PubMed
 
3. White WB, Cannon CP, Heller SR, Nissen SE, Bergenstal RM, Bakris GL, Perez AT, Fleck PR, Mehta CR, Kupfer S, Wilson C, Cushman WC, Zannad F. Alogliptin after acute coronary syndrome in patients with type 2 diabetes. N Engl J Med. 2013 Oct 3; 369(14):1327-35.
  View in: PubMed
 
4. White WB, Cooke GE, Kowey PR, Calverley PM, Bredenbröker D, Goehring UM, Zhu H, Lakkis H, Mosberg H, Rowe P, Rabe KF. Cardiovascular Safety in Patients Receiving Roflumilast for the Treatment of COPD. Chest. 2013 Sep; 144(3):758-65.
  View in: PubMed
 
5. Gulati V, White WB. Review of the state of renal nerve ablation for patients with severe and resistant hypertension. J Am Soc Hypertens. 2013 Nov-Dec; 7(6):484-93.
  View in: PubMed
 
6. White WB, Sager PT. Response to Letter to the Editor by Blankfield regarding "Assessment of drug-induced increases in blood pressure during drug development: report from the Cardiac Safety Research Consortium.". Am Heart J. 2013 Sep; 166(3):e11.
  View in: PubMed
 
7. Wolfson L, Wakefield DB, Moscufo N, Kaplan RF, Hall CB, Schmidt JA, Guttmann CR, White WB. Rapid buildup of brain white matter hyperintensities over 4 years linked to ambulatory blood pressure, mobility, cognition, and depression in old persons. J Gerontol A Biol Sci Med Sci. 2013 Nov; 68(11):1387-94.
  View in: PubMed
 
8. Elliott WJ, Egan B, Giles TD, Bakris GL, White WB, Sansone TM. Rationale for establishing a mechanism to increase reimbursement to hypertension specialists. J Clin Hypertens (Greenwich). 2013 Jun; 15(6):397-403.
  View in: PubMed
 
9. Oelsner EC, Pottinger TD, Burkart KM, Allison M, Buxbaum SG, Hansel NN, Kumar R, Larkin EK, Lange LA, Loehr LR, London SJ, O'Connor GT, Papanicolaou G, Petrini MF, Rabinowitz D, Raghavan S, Redline S, Thyagarajan B, Tracy RP, Wilk JB, White WB, Rich SS, Barr RG. Adhesion molecules, endothelin-1 and lung function in seven population-based cohorts. Biomarkers. 2013 May; 18(3):196-203.
  View in: PubMed
 
10. White WB, Pratley R, Fleck P, Munsaka M, Hisada M, Wilson C, Menon V. Cardiovascular safety of the dipetidyl peptidase-4 inhibitor alogliptin in type 2 diabetes mellitus. Diabetes Obes Metab. 2013 Jul; 15(7):668-73.
  View in: PubMed
 
11. Bönner G, Bakris GL, Sica D, Weber MA, White WB, Perez A, Cao C, Handley A, Kupfer S. Antihypertensive efficacy of the angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril. J Hum Hypertens. 2013 Aug; 27(8):479-86.
  View in: PubMed
 
12. Cavallari M, Moscufo N, Skudlarski P, Meier D, Panzer VP, Pearlson GD, White WB, Wolfson L, Guttmann CR. Mobility impairment is associated with reduced microstructural integrity of the inferior and superior cerebellar peduncles in elderly with no clinical signs of cerebellar dysfunction. Neuroimage Clin. 2013; 2:332-40.
  View in: PubMed
 
13. Sager P, Heilbraun J, Turner JR, Gintant G, Geiger MJ, Kowey PR, Mansoor GA, Mendzelevski B, Michelson EL, Stockbridge N, Weber MA, White WB. Assessment of drug-induced increases in blood pressure during drug development: report from the Cardiac Safety Research Consortium. Am Heart J. 2013 Apr; 165(4):477-88.
  View in: PubMed
 
14. White WB, Marfatia R, Schmidt J, Wakefield DB, Kaplan RF, Bohannon RW, Hall CB, Guttmann CR, Moscufo N, Fellows D, Wolfson L. INtensive versus standard ambulatory blood pressure lowering to prevent functional DeclINe in the ElderlY (INFINITY). Am Heart J. 2013 Mar; 165(3):258-265.e1.
  View in: PubMed
 
15. Sobieraj DM, White WB, Baker WL. Cardiovascular effects of pharmacologic therapies for smoking cessation. J Am Soc Hypertens. 2013 Jan-Feb; 7(1):61-7.
  View in: PubMed
 
16. Wagner JA, Tennen H, Finan PH, White WB, Burg MM, Ghuman N. Lifetime history of depression, type 2 diabetes, and endothelial reactivity to acute stress in postmenopausal women. Int J Behav Med. 2012 Dec; 19(4):503-11.
  View in: PubMed
 
17. Bakris GL, Sica D, White WB, Cushman WC, Weber MA, Handley A, Song E, Kupfer S. Antihypertensive efficacy of hydrochlorothiazide vs chlorthalidone combined with azilsartan medoxomil. Am J Med. 2012 Dec; 125(12):1229.e1-1229.e10.
  View in: PubMed
 
18. Giles TD, Black HR, Messerli F, White WB. Ambulatory blood pressure monitoring should be included in the National Health and Nutritional Examination Survey (NHANES). J Am Soc Hypertens. 2012 Sep-Oct; 6(5):364-6.
  View in: PubMed
 
19. White WB. Module 1: Historical review of evidence-based treatment of hypertension. J Fam Pract. 2012 Aug; 61(8 Suppl):S5-14; quiz S27.
  View in: PubMed
 
20. White WB, Maraka S. Is it possible to manage hypertension and evaluate therapy without ambulatory blood pressure monitoring? Curr Hypertens Rep. 2012 Aug; 14(4):366-73.
  View in: PubMed
 
21. Petry NM, Rash CJ, Byrne S, Ashraf S, White WB. Financial reinforcers for improving medication adherence: findings from a meta-analysis. Am J Med. 2012 Sep; 125(9):888-96.
  View in: PubMed
 
22. Marfatia R, White WB, Schumacher H. Effects of Telmisartan with Hydrochlorothiazide versus Valsartan with Hydrochlorothiazide in Patients with Moderate-to-Severe Hypertension. Int J Hypertens. 2012; 2012:976828.
  View in: PubMed
 
23. Cushman WC, Bakris GL, White WB, Weber MA, Sica D, Roberts A, Lloyd E, Kupfer S. Azilsartan medoxomil plus chlorthalidone reduces blood pressure more effectively than olmesartan plus hydrochlorothiazide in stage 2 systolic hypertension. Hypertension. 2012 Aug; 60(2):310-8.
  View in: PubMed
 
24. White WB, Chohan S, Dabholkar A, Hunt B, Jackson R. Cardiovascular safety of febuxostat and allopurinol in patients with gout and cardiovascular comorbidities. Am Heart J. 2012 Jul; 164(1):14-20.
  View in: PubMed
 
25. Baker WL, White WB. Safety of mineralocorticoid receptor antagonists in patients receiving hemodialysis. Ann Pharmacother. 2012 Jun; 46(6):889-94.
  View in: PubMed
 
26. White WB. "The nighttime might be the right time" for cardiovascular event prediction. Hypertension. 2012 Jul; 60(1):8-9.
  View in: PubMed
 
27. Marfatia R, Kaloudis E, Tendler BE, White WB. Intramural hematoma of the aorta as a presenting sign of accelerated hypertension. Am J Med. 2012 Jul; 125(7):e5-6.
  View in: PubMed
 
28. White WB. The present and future of the American Society of Hypertension-2012. J Clin Hypertens (Greenwich). 2012 Jun; 14(6):401-3.
  View in: PubMed
 
29. White WB. The present and future of the American Society of Hypertension: 2012. J Am Soc Hypertens. 2012 May-Jun; 6(3):237-9.
  View in: PubMed
 
30. Sica D, Bakris GL, White WB, Weber MA, Cushman WC, Huang P, Roberts A, Kupfer S. Blood pressure-lowering efficacy of the fixed-dose combination of azilsartan medoxomil and chlorthalidone: a factorial study. J Clin Hypertens (Greenwich). 2012 May; 14(5):284-92.
  View in: PubMed
 
31. Flack JM, Yadao AM, Purkayastha D, Samuel R, White WB. Comparison of the effects of aliskiren/valsartan in combination versus valsartan alone in patients with stage 2 hypertension. J Am Soc Hypertens. 2012 Mar-Apr; 6(2):142-51.
  View in: PubMed
 
32. Baker WL, White WB. Azilsartan medoxomil: a new angiotensin II receptor antagonist for treatment of hypertension. Ann Pharmacother. 2011 Dec; 45(12):1506-15.
  View in: PubMed
 
33. White WB, Wolfson L, Wakefield DB, Hall CB, Campbell P, Moscufo N, Schmidt J, Kaplan RF, Pearlson G, Guttmann CR. Average daily blood pressure, not office blood pressure, is associated with progression of cerebrovascular disease and cognitive decline in older people. Circulation. 2011 Nov 22; 124(21):2312-9.
  View in: PubMed
 
34. White WB, Grady D, Giudice LC, Berry SM, Zborowski J, Snabes MC. A cardiovascular safety study of LibiGel (testosterone gel) in postmenopausal women with elevated cardiovascular risk and hypoactive sexual desire disorder. Am Heart J. 2012 Jan; 163(1):27-32.
  View in: PubMed
 
35. White WB, Derosier FJ, Thompson AH, Adams BE, Goodman DK. Evaluation of the migraine treatment sumatriptan/naproxen sodium on blood pressure following long-term administration. J Clin Hypertens (Greenwich). 2011 Dec; 13(12):910-6.
  View in: PubMed
 
36. Calhoun DA, White WB, Krum H, Guo W, Bermann G, Trapani A, Lefkowitz MP, Ménard J. Effects of a novel aldosterone synthase inhibitor for treatment of primary hypertension: results of a randomized, double-blind, placebo- and active-controlled phase 2 trial. Circulation. 2011 Nov 1; 124(18):1945-55.
  View in: PubMed
 
37. White WB, Bakris GL, Bergenstal RM, Cannon CP, Cushman WC, Fleck P, Heller S, Mehta C, Nissen SE, Perez A, Wilson C, Zannad F. EXamination of cArdiovascular outcoMes with alogliptIN versus standard of carE in patients with type 2 diabetes mellitus and acute coronary syndrome (EXAMINE): a cardiovascular safety study of the dipeptidyl peptidase 4 inhibitor alogliptin in patients with type 2 diabetes with acute coronary syndrome. Am Heart J. 2011 Oct; 162(4):620-626.e1.
  View in: PubMed
 
38. Campbell P, Baker WL, Bendel SD, White WB. Intravenous hydralazine for blood pressure management in the hospitalized patient: its use is often unjustified. J Am Soc Hypertens. 2011 Nov-Dec; 5(6):473-7.
  View in: PubMed
 
39. Sundy JS, Baraf HS, Yood RA, Edwards NL, Gutierrez-Urena SR, Treadwell EL, Vázquez-Mellado J, White WB, Lipsky PE, Horowitz Z, Huang W, Maroli AN, Waltrip RW, Hamburger SA, Becker MA. Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: two randomized controlled trials. JAMA. 2011 Aug 17; 306(7):711-20.
  View in: PubMed
 
40. Petry NM, Barry D, Pescatello L, White WB. A low-cost reinforcement procedure improves short-term weight loss outcomes. Am J Med. 2011 Nov; 124(11):1082-5.
  View in: PubMed
 
41. Gorelick PB, White WB. ß-Blockers in neurologic practice: should we be advising caution? Neurology. 2011 Aug 23; 77(8):708-9.
  View in: PubMed
 
42. White WB, Petry NM. Home blood pressure monitoring as an intervention to control hypertension: comment on "Home blood pressure management and improved blood pressure control". Arch Intern Med. 2011 Jul 11; 171(13):1181-2.
  View in: PubMed
 
43. Campbell P, Singh KP, Schuchard G, Jain K, White WB. Severe circadian hypertension in a young man. Am J Med. 2011 Oct; 124(10):e1-2.
  View in: PubMed
 
44. Sica D, White WB, Weber MA, Bakris GL, Perez A, Cao C, Handley A, Kupfer S. Comparison of the novel angiotensin II receptor blocker azilsartan medoxomil vs valsartan by ambulatory blood pressure monitoring. J Clin Hypertens (Greenwich). 2011 Jul; 13(7):467-72.
  View in: PubMed
 
45. Boldo A, White WB. Blood pressure effects of the oral contraceptive and postmenopausal hormone therapies. Endocrinol Metab Clin North Am. 2011 Jun; 40(2):419-32, ix.
  View in: PubMed
 
46. Parthasarathy HK, Ménard J, White WB, Young WF, Williams GH, Williams B, Ruilope LM, McInnes GT, Connell JM, MacDonald TM. A double-blind, randomized study comparing the antihypertensive effect of eplerenone and spironolactone in patients with hypertension and evidence of primary aldosteronism. J Hypertens. 2011 May; 29(5):980-90.
  View in: PubMed
 
47. White WB, Kostis JB. Leadership message. American Society of Hypertension-designated centers of excellence: a new initiative. J Clin Hypertens (Greenwich). 2011 May; 13(5):391-2.
  View in: PubMed
 
48. White WB, Bresalier R, Kaplan AP, Palmer BF, Riddell RH, Lesogor A, Chang W, Keefe DL. Safety and tolerability of the direct renin inhibitor aliskiren in combination with angiotensin receptor blockers and thiazide diuretics: a pooled analysis of clinical experience of 12,942 patients. J Clin Hypertens (Greenwich). 2011 Jul; 13(7):506-16.
  View in: PubMed
 
49. White WB, Schnitzer TJ, Bakris GL, Frayssinet H, Duquesroix B, Weber M. Effects of naproxcinod on blood pressure in patients with osteoarthritis. Am J Cardiol. 2011 May 1; 107(9):1338-45.
  View in: PubMed
 
50. Bakris GL, Sica D, Weber M, White WB, Roberts A, Perez A, Cao C, Kupfer S. The comparative effects of azilsartan medoxomil and olmesartan on ambulatory and clinic blood pressure. J Clin Hypertens (Greenwich). 2011 Feb; 13(2):81-8.
  View in: PubMed
 
51. White WB, Weber MA, Sica D, Bakris GL, Perez A, Cao C, Kupfer S. Effects of the angiotensin receptor blocker azilsartan medoxomil versus olmesartan and valsartan on ambulatory and clinic blood pressure in patients with stages 1 and 2 hypertension. Hypertension. 2011 Mar; 57(3):413-20.
  View in: PubMed
 
52. White WB, Campbell P. Blood pressure destabilization on nonsteroidal antiinflammatory agents: acetaminophen exposed? Circulation. 2010 Nov 2; 122(18):1779-81.
  View in: PubMed
 
53. White WB, Bresalier R, Kaplan AP, Palmer BF, Riddell RH, Lesogor A, Chang W, Keefe DL. Safety and tolerability of the direct renin inhibitor aliskiren: a pooled analysis of clinical experience in more than 12,000 patients with hypertension. J Clin Hypertens (Greenwich). 2010 Oct; 12(10):765-75.
  View in: PubMed
 
54. Friedewald VE, Bennett JS, Christo JP, Pool JL, Scheiman JM, Simon LS, Strand V, White WB, Williams GW, Roberts WC. AJC Editor's consensus: Selective and nonselective nonsteroidal anti-inflammatory drugs and cardiovascular risk. Am J Cardiol. 2010 Sep 15; 106(6):873-84.
  View in: PubMed
 
55. White WB, Littlejohn TW, Majul CR, Oigman W, Olvera R, Seeber M, Schumacher H, Mancia G. Effects of telmisartan and amlodipine in combination on ambulatory blood pressure in stages 1-2 hypertension. Blood Press Monit. 2010 Aug; 15(4):205-12.
  View in: PubMed
 
56. Friedewald VE, Ram CV, Wesson DE, White WB, Williams GW, Roberts WC. The editor's roundtable: effect of nonsteroidal anti-inflammatory drugs on blood pressure. Am J Cardiol. 2010 Jun 15; 105(12):1759-67.
  View in: PubMed
 
57. White WB. Hypertension: antihypertensive class matters for combination therapy. Nat Rev Cardiol. 2010 Jun; 7(6):303-4.
  View in: PubMed
 
58. O'Brien E, White WB. Thomas G. Pickering: friend, colleague and scientist. Blood Press Monit. 2010 Apr; 15(2):67-9.
  View in: PubMed
 
59. White WB. The risk of waking-up: impact of the morning surge in blood pressure. Hypertension. 2010 Apr; 55(4):835-7.
  View in: PubMed
 
60. Campbell P, Ghuman N, Wakefield D, Wolfson L, White WB. Long-term reproducibility of ambulatory blood pressure is superior to office blood pressure in the very elderly. J Hum Hypertens. 2010 Nov; 24(11):749-54.
  View in: PubMed
 
61. Pickering TG, White WB, Giles TD, Black HR, Izzo JL, Materson BJ, Oparil S, Weber MA. When and how to use self (home) and ambulatory blood pressure monitoring. J Am Soc Hypertens. 2010 Mar-Apr; 4(2):56-61.
  View in: PubMed
 
62. Boldo A, Campbell P, Luthra P, White WB. Should the concentration of vitamin D be measured in all patients with hypertension? J Clin Hypertens (Greenwich). 2010 Mar; 12(3):149-52.
  View in: PubMed
 
63. Ghuman N, Tendler B, Gjertson CK, Kaur M, Moskowitz H, White WB. Radiating abdominal pain and hypertension. Am J Med. 2009 Dec; 122(12):1103-5.
  View in: PubMed
 
64. Ghuman N, Rheiner J, Tendler BE, White WB. Hypertension in the postpartum woman: clinical update for the hypertension specialist. J Clin Hypertens (Greenwich). 2009 Dec; 11(12):726-33.
  View in: PubMed
 
65. White WB. In Memoriam: Thomas G. Pickering 1940-2009. Hypertension. 2009 Nov; 54(5):917-8.
  View in: PubMed
 
66. Ghuman N, Campbell P, White WB. Role of ambulatory and home blood pressure recording in clinical practice. Curr Cardiol Rep. 2009 Nov; 11(6):414-21.
  View in: PubMed
 
67. White WB, Schnitzer TJ, Fleming R, Duquesroix B, Beekman M. Effects of the cyclooxygenase inhibiting nitric oxide donator naproxcinod versus naproxen on systemic blood pressure in patients with osteoarthritis. Am J Cardiol. 2009 Sep 15; 104(6):840-5.
  View in: PubMed
 
68. White WB. The potential role of nitric oxide in cardiovascular safety when treating osteoarthritis in patients with hypertension. Introduction. Am J Med. 2009 May; 122(5 Suppl):S1-2.
  View in: PubMed
 
69. White WB, Pepine CJ, Weber MA. The potential role of nitric oxide in cardiovascular safety when treating patients with osteoarthritis and hypertension: a moderated panel discussion. Am J Med. 2009 May; 122(5 Suppl):S23-5.
  View in: PubMed
 
70. White WB. Defining the problem of treating the patient with hypertension and arthritis pain. Am J Med. 2009 May; 122(5 Suppl):S3-9.
  View in: PubMed
 
71. White WB, Davidai G, Schumacher H. Impact of angiotensin receptor blockade in combination with hydrochlorothiazide 25 mg in 2121 patients with stage 1-2 hypertension. J Hum Hypertens. 2009 Dec; 23(12):817-25.
  View in: PubMed
 
72. Khanna A, White WB. The management of hyperkalemia in patients with cardiovascular disease. Am J Med. 2009 Mar; 122(3):215-21.
  View in: PubMed
 
73. Endeshaw YW, White WB, Kutner M, Ouslander JG, Bliwise DL. Sleep-disordered breathing and 24-hour blood pressure pattern among older adults. J Gerontol A Biol Sci Med Sci. 2009 Feb; 64(2):280-5.
  View in: PubMed
 
74. Pickering TG, White WB. ASH Position Paper: Home and ambulatory blood pressure monitoring. When and how to use self (home) and ambulatory blood pressure monitoring. J Clin Hypertens (Greenwich). 2008 Nov; 10(11):850-5.
  View in: PubMed
 
75. Khanna A, Lefkowitz L, White WB. Evaluation of recent fixed-dose combination therapies in the management of hypertension. Curr Opin Nephrol Hypertens. 2008 Sep; 17(5):477-83.
  View in: PubMed
 
76. White WB, Salzman P, Schwid SR. Transtelephonic home blood pressure to assess the monoamine oxidase-B inhibitor rasagiline in Parkinson disease. Hypertension. 2008 Sep; 52(3):587-93.
  View in: PubMed
 
77. White WB. Management of hypertension in patients with enhanced cardiovascular risk. Introduction. Am J Med. 2008 Aug; 121(8 Suppl):S1.
  View in: PubMed
 
78. White WB. Relating cardiovascular risk to out-of-office blood pressure and the importance of controlling blood pressure 24 hours a day. Am J Med. 2008 Aug; 121(8 Suppl):S2-7.
  View in: PubMed
 
79. Kario K, White WB. Early morning hypertension: what does it contribute to overall cardiovascular risk assessment? J Am Soc Hypertens. 2008 Nov-Dec; 2(6):397-402.
  View in: PubMed
 
80. Calhoun DA, White WB. Effectiveness of the selective aldosterone blocker, eplerenone, in patients with resistant hypertension. J Am Soc Hypertens. 2008 Nov-Dec; 2(6):462-8.
  View in: PubMed
 
81. White WB, Krishnan S, Giacco S, Mallareddy M. Effects of metoprolol succinate extended release vs. amlodipine besylate on the blood pressure, heart rate, and the rate-pressure product in patients with hypertension. J Am Soc Hypertens. 2008 Sep-Oct; 2(5):378-84.
  View in: PubMed
 
82. Labinson PT, Giacco S, Gift H, Mansoor GA, White WB. The importance of the clinical observer in the development of a white-coat effect in African-American patients with hypertension. Blood Press Monit. 2008 Jun; 13(3):139-42.
  View in: PubMed
 
83. White WB, Calhoun DA, Samuel R, Taylor AA, Zappe DH, Purkayastha D. Improving blood pressure control: increase the dose of diuretic or switch to a fixed-dose angiotensin receptor blocker/diuretic? the valsartan hydrochlorothiazide diuretic for initial control and titration to achieve optimal therapeutic effect (Val-DICTATE) trial. J Clin Hypertens (Greenwich). 2008 Jun; 10(6):450-8.
  View in: PubMed
 
84. Moser M, Rosendorff C, White WB. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: is there a difference in response and any advantage to using them together in the treatment of hypertension? J Clin Hypertens (Greenwich). 2008 Jun; 10(6):489-96.
  View in: PubMed
 
85. White WB, Cleveland JM, Rolleri RL. Utility of semiautomatic clinic and 24-h ambulatory blood pressure measurements to evaluate combination therapy: the Ramipril-Hydrochlorothiazide Hypertension trial. J Hum Hypertens. 2008 Aug; 22(8):559-68.
  View in: PubMed
 
86. Pickering TG, White WB. When and how to use self (home) and ambulatory blood pressure monitoring. J Am Soc Hypertens. 2008 May-Jun; 2(3):119-24.
  View in: PubMed
 
87. Rykaczewski K, Marshall A, White WB, Fedorov AG. Dynamic growth of carbon nanopillars and microrings in electron beam induced dissociation of residual hydrocarbons. Ultramicroscopy. 2008 Aug; 108(9):989-92.
  View in: PubMed
 
88. White WB. Improving blood pressure control and clinical outcomes through initial use of combination therapy in stage 2 hypertension. Blood Press Monit. 2008 Apr; 13(2):123-9.
  View in: PubMed
 
89. White WB, Murwin D, Chrysant SG, Koval SE, Davidai G, Guthrie R. Effects of the angiotensin II receptor blockers telmisartan versus valsartan in combination with hydrochlorothiazide: a large, confirmatory trial. Blood Press Monit. 2008 Feb; 13(1):21-7.
  View in: PubMed
 
90. Laine L, White WB, Rostom A, Hochberg M. COX-2 selective inhibitors in the treatment of osteoarthritis. Semin Arthritis Rheum. 2008 Dec; 38(3):165-87.
  View in: PubMed
 
91. Plosker GL, White WB. Telmisartan/Hydrochlorothiazide: a review of its use as fixed-dose combinations in essential hypertension. Drugs. 2008; 68(13):1877-99.
  View in: PubMed
 
92. White WB, Hanes V, Mallareddy M, Chauhan V. Effects of the hormone therapy, drospirenone and 17-beta estradiol, on early morning blood pressure in postmenopausal women with hypertension. J Am Soc Hypertens. 2008 Jan-Feb; 2(1):20-7.
  View in: PubMed
 
93. White WB. Cardiovascular risk, hypertension, and NSAIDs. Curr Pain Headache Rep. 2007 Dec; 11(6):428-35.
  View in: PubMed
 
94. White WB. Angiotensin-converting enzyme inhibitors in the treatment of hypertension: an update. J Clin Hypertens (Greenwich). 2007 Nov; 9(11):876-82.
  View in: PubMed
 
95. Herbst S, Pietrzak RH, Wagner J, White WB, Petry NM. Lifetime major depression is associated with coronary heart disease in older adults: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Psychosom Med. 2007 Nov; 69(8):729-34.
  View in: PubMed
 
96. White WB. Importance of blood pressure control over a 24-hour period. J Manag Care Pharm. 2007 Oct; 13(8 Suppl B):34-9.
  View in: PubMed
 
97. White WB. Importance of aggressive blood pressure lowering when it may matter most. Am J Cardiol. 2007 Aug 6; 100(3A):10J-16J.
  View in: PubMed
 
98. Toran L, Herman EK, White WB. Comparison of flowpaths to a well and spring in a karst aquifer. Ground Water. 2007 May-Jun; 45(3):281-7.
  View in: PubMed
 
99. White WB. The riskiest time for the brain: could the nighttime be the right time for intervention? Hypertension. 2007 Jun; 49(6):1215-6.
  View in: PubMed
 
100. White WB. Cardiovascular risk, hypertension, and NSAIDs. Curr Rheumatol Rep. 2007 Apr; 9(1):36-43.
  View in: PubMed
 
101. White WB. Pharmacologic agents in the management of hypertension--nisoldipine coat-core. J Clin Hypertens (Greenwich). 2007 Apr; 9(4):259-66.
  View in: PubMed
 
102. Peixoto AJ, White WB. Circadian blood pressure: clinical implications based on the pathophysiology of its variability. Kidney Int. 2007 May; 71(9):855-60.
  View in: PubMed
 
103. White WB. Drospirenone with 17beta-estradiol in the postmenopausal woman with hypertension. Climacteric. 2007 Feb; 10 Suppl 1:25-31.
  View in: PubMed
 
104. White WB. Cardiovascular effects of the cyclooxygenase inhibitors. Hypertension. 2007 Mar; 49(3):408-18.
  View in: PubMed
 
105. White WB. Ambulatory blood pressure monitoring as an investigative tool for characterizing resistant hypertension and its rational treatment. J Clin Hypertens (Greenwich). 2007 Jan; 9(1 Suppl 1):25-30.
  View in: PubMed
 
106. White WB. Smoking-related morbidity and mortality in the cardiovascular setting. Prev Cardiol. 2007; 10(2 Suppl 1):1-4.
  View in: PubMed
 
107. Mallareddy M, Hanes V, White WB. Drospirenone, a new progestogen, for postmenopausal women with hypertension. Drugs Aging. 2007; 24(6):453-66.
  View in: PubMed
 
108. White WB. Cardiovascular effects of the selective cyclooxygenase-2 inhibitors. Subcell Biochem. 2007; 42:145-58.
  View in: PubMed
 
109. White WB. Clinical assessment of early morning blood pressure in patients with hypertension. Prev Cardiol. 2007; 10(4):210-4.
  View in: PubMed
 
110. White WB, West CR, Borer JS, Gorelick PB, Lavange L, Pan SX, Weiner E, Verburg KM. Risk of cardiovascular events in patients receiving celecoxib: a meta-analysis of randomized clinical trials. Am J Cardiol. 2007 Jan 1; 99(1):91-8.
  View in: PubMed
 
111. deMarcaida JA, Schwid SR, White WB, Blindauer K, Fahn S, Kieburtz K, Stern M, Shoulson I. Effects of tyramine administration in Parkinson's disease patients treated with selective MAO-B inhibitor rasagiline. Mov Disord. 2006 Oct; 21(10):1716-21.
  View in: PubMed
 
112. White WB, Punzi HA, Murwin D, Koval SE, Davidai G, Neutel JM. Effects of the angiotensin II receptor blockers telmisartan vs valsartan in combination with hydrochlorothiazide 25 mg once daily for the treatment of hypertension. J Clin Hypertens (Greenwich). 2006 Sep; 8(9):626-33.
  View in: PubMed
 
113. White WB, Rykaczewski K, Fedorov AG. What controls deposition rate in electron-beam chemical vapor deposition? Phys Rev Lett. 2006 Aug 25; 97(8):086101.
  View in: PubMed
 
114. White WB, Hanes V, Chauhan V, Pitt B. Effects of a new hormone therapy, drospirenone and 17-beta-estradiol, in postmenopausal women with hypertension. Hypertension. 2006 Aug; 48(2):246-53.
  View in: PubMed
 
115. Labinson PT, White WB, Tendler BE, Mansoor GA. Primary hyperaldosteronism associated with hypertensive emergencies. Am J Hypertens. 2006 Jun; 19(6):623-7.
  View in: PubMed
 
116. Weber MA, White WB, Giles TD, Bakris GL, Neutel JM, Smith DH, Davidai G. An effectiveness study comparing algorithm-based antihypertensive therapy with previous treatments using conventional and ambulatory blood pressure measurements. J Clin Hypertens (Greenwich). 2006 Apr; 8(4):241-50; quiz 251-2.
  View in: PubMed
 
117. Wang J, White WB, Adair JH. Dispersion of SiO2-based nanocomposites with high performance liquid chromatography. J Phys Chem B. 2006 Mar 16; 110(10):4679-85.
  View in: PubMed
 
118. White WB, Giles T, Bakris GL, Neutel JM, Davidai G, Weber MA. Measuring the efficacy of antihypertensive therapy by ambulatory blood pressure monitoring in the primary care setting. Am Heart J. 2006 Jan; 151(1):176-84.
  View in: PubMed
 
119. White WB. Expanding the use of ambulatory blood pressure monitoring for the diagnosis and management of patients with hypertension. Hypertension. 2006 Jan; 47(1):14-5.
  View in: PubMed
 
120. White WB, Parke AL. Acute pain in the tip of the index finger. Am J Med. 2005 Nov; 118(11):1223-4.
  View in: PubMed
 
121. Bakris GL, Smith DH, Giles TD, White WB, Davidai G, Weber MA. Comparative antihypertensive efficacy of angiotensin receptor blocker-based treatment in African-American and white patients. J Clin Hypertens (Greenwich). 2005 Oct; 7(10):587-95; quiz 596-7.
  View in: PubMed
 
122. White WB, Pitt B, Preston RA, Hanes V. Antihypertensive effects of drospirenone with 17beta-estradiol, a novel hormone treatment in postmenopausal women with stage 1 hypertension. Circulation. 2005 Sep 27; 112(13):1979-84.
  View in: PubMed
 
123. Weinberger MH, White WB, Ruilope LM, MacDonald TM, Davidson RC, Roniker B, Patrick JL, Krause SL. Effects of eplerenone versus losartan in patients with low-renin hypertension. Am Heart J. 2005 Sep; 150(3):426-33.
  View in: PubMed
 
124. White WB. Update on the drug treatment of hypertension in patients with cardiovascular disease. Am J Med. 2005 Jul; 118(7):695-705.
  View in: PubMed
 
125. White WB, Weber MA, Davidai G, Neutel JM, Bakris GL, Giles T. Ambulatory blood pressure monitoring in the primary care setting: assessment of therapy on the circadian variation of blood pressure from the MICCAT-2 Trial. Blood Press Monit. 2005 Jun; 10(3):157-63.
  View in: PubMed
 
126. Preston RA, White WB, Pitt B, Bakris G, Norris PM, Hanes V. Effects of drospirenone/17-beta estradiol on blood pressure and potassium balance in hypertensive postmenopausal women. Am J Hypertens. 2005 Jun; 18(6):797-804.
  View in: PubMed
 
127. Black HR, Elliott WJ, Grandits G, Grambsch P, Lucente T, Neaton JD, Grimm RH, Hansson L, Lacourcière Y, Muller JE, Sleight P, Weber MA, White WB, Williams GH, Wittes J, Zanchetti A, Anders RJ. Results of the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) trial by geographical region. J Hypertens. 2005 May; 23(5):1099-106.
  View in: PubMed
 
128. White WB, Moon T. Treatment of benign prostatic hyperplasia in hypertensive men. J Clin Hypertens (Greenwich). 2005 Apr; 7(4):212-7.
  View in: PubMed
 
129. Sowers JR, White WB, Pitt B, Whelton A, Simon LS, Winer N, Kivitz A, van Ingen H, Brabant T, Fort JG. The Effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus. Arch Intern Med. 2005 Jan 24; 165(2):161-8.
  View in: PubMed
 
130. Simon LS, White WB. COX-2 selective inhibitors and heart health. Postgrad Med. 2005 Jan; 117(1 Suppl):7-20.
  View in: PubMed
 
131. White WB. Hypertension management: differing points of view: ambulatory blood pressure monitoring for every hypertensive patient: it's about time!: the argument against. J Clin Hypertens (Greenwich). 2004 Dec; 6(12):710-3; quiz 714.
  View in: PubMed
 
132. Auerbach SM, Gittelman M, Mazzu A, Cihon F, Sundaresan P, White WB. Simultaneous administration of vardenafil and tamsulosin does not induce clinically significant hypotension in patients with benign prostatic hyperplasia. Urology. 2004 Nov; 64(5):998-1003; discussion 1003-4.
  View in: PubMed
 
133. Mansoor GA, White WB. Self-measured home blood pressure in predicting ambulatory hypertension. Am J Hypertens. 2004 Nov; 17(11 Pt 1):1017-22.
  View in: PubMed
 
134. White WB, Lacourciere Y. Effects of telmisartan 80 mg and valsartan 160 mg on ambulatory blood pressure in patients with essential hypertension. J Hypertens. 2004 Oct; 22(10):2035-6; author reply 2036-8.
  View in: PubMed
 
135. White WB, Lacourciere Y, Gana T, Pascual MG, Smith DH, Albert KS. Effects of graded-release diltiazem versus ramipril, dosed at bedtime, on early morning blood pressure, heart rate, and the rate-pressure product. Am Heart J. 2004 Oct; 148(4):628-34.
  View in: PubMed
 
136. Elliot WJ, Izzo JL, White WB, Rosing DR, Snyder CS, Alter A, Gavish B, Black HR. Graded blood pressure reduction in hypertensive outpatients associated with use of a device to assist with slow breathing. J Clin Hypertens (Greenwich). 2004 Oct; 6(10):553-9; quiz 560-1.
  View in: PubMed
 
137. Lacourcière Y, Krzesinski JM, White WB, Davidai G, Schumacher H. Sustained antihypertensive activity of telmisartan compared with valsartan. Blood Press Monit. 2004 Aug; 9(4):203-10.
  View in: PubMed
 
138. White WB, Strand V, Roberts R, Whelton A. Effects of the cyclooxygenase-2 specific inhibitor valdecoxib versus nonsteroidal antiinflammatory agents and placebo on cardiovascular thrombotic events in patients with arthritis. Am J Ther. 2004 Jul-Aug; 11(4):244-50.
  View in: PubMed
 
139. White WB. Hypertension associated with therapies to treat arthritis and pain. Hypertension. 2004 Aug; 44(2):123-4.
  View in: PubMed
 
140. White WB, Lacourciere Y, Davidai G. Effects of the angiotensin II receptor blockers telmisartan versus valsartan on the circadian variation of blood pressure: impact on the early morning period. Am J Hypertens. 2004 Apr; 17(4):347-53.
  View in: PubMed
 
141. White WB, Larocca GM. Improving the utility of the nocturnal hypertension definition by using absolute sleep blood pressure rather than the "dipping" proportion. Am J Cardiol. 2003 Dec 15; 92(12):1439-41.
  View in: PubMed
 
142. Mendes RB, Santos SF, Dorigo D, Mansoor GA, Crowley ST, White WB, Peixoto AJ. The use of peridialysis blood pressure and intradialytic blood pressure changes in the prediction of interdialytic blood pressure in haemodialysis patients. Blood Press Monit. 2003 Dec; 8(6):243-8.
  View in: PubMed
 
143. Thavarajah S, White WB, Mansoor GA. Terminal digit bias in a specialty hypertension faculty practice. J Hum Hypertens. 2003 Dec; 17(12):819-22.
  View in: PubMed
 
144. Bansal N, Tendler BE, White WB, Mansoor GA. Blood pressure control in the hypertension clinic. Am J Hypertens. 2003 Oct; 16(10):878-80.
  View in: PubMed
 
145. Weber MA, White WB. Evaluation of the 24 h effects of the angiotensin II receptor blockers: means to improve cardiovascular outcomes? Blood Press Monit. 2003 Oct; 8(5):215-22.
  View in: PubMed
 
146. White WB, Saunders E, Noveck RJ, Ferdinand K. Comparative efficacy and safety of nisoldipine extended-release (ER) and amlodipine (CESNA-III study) in African American patients with hypertension. Am J Hypertens. 2003 Sep; 16(9 Pt 1):739-45.
  View in: PubMed
 
147. White WB, Faich G, Borer JS, Makuch RW. Cardiovascular thrombotic events in arthritis trials of the cyclooxygenase-2 inhibitor celecoxib. Am J Cardiol. 2003 Aug 15; 92(4):411-8.
  View in: PubMed
 
148. White WB. Relevance of blood pressure variation in the circadian onset of cardiovascular events. J Hypertens Suppl. 2003 Jul; 21(6):S9-15.
  View in: PubMed
 
149. White WB, Carr AA, Krause S, Jordan R, Roniker B, Oigman W. Assessment of the novel selective aldosterone blocker eplerenone using ambulatory and clinical blood pressure in patients with systemic hypertension. Am J Cardiol. 2003 Jul 1; 92(1):38-42.
  View in: PubMed
 
150. Arias-Vera JR, Mansoor GA, White WB. Abnormalities in blood pressure regulation in a patient with Parkinson's disease. Am J Hypertens. 2003 Jul; 16(7):612-3.
  View in: PubMed
 
151. White WB. Ambulatory blood-pressure monitoring in clinical practice. N Engl J Med. 2003 Jun 12; 348(24):2377-8.
  View in: PubMed
 
152. White WB, Herbst T, Thavarajah S, Giacco S. Clinical evaluation of the Trimline blood pressure cuffs with the Accutorr Plus Monitor. Blood Press Monit. 2003 Jun; 8(3):137-40.
  View in: PubMed
 
153. Ball SG, White WB. Debate: angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers--a gap in evidence-based medicine. Am J Cardiol. 2003 May 22; 91(10A):15G-21G.
  View in: PubMed
 
154. White WB, Duprez D, St Hillaire R, Krause S, Roniker B, Kuse-Hamilton J, Weber MA. Effects of the selective aldosterone blocker eplerenone versus the calcium antagonist amlodipine in systolic hypertension. Hypertension. 2003 May; 41(5):1021-6.
  View in: PubMed
 
155. Black HR, Elliott WJ, Grandits G, Grambsch P, Lucente T, White WB, Neaton JD, Grimm RH, Hansson L, Lacourciere Y, Muller J, Sleight P, Weber MA, Williams G, Wittes J, Zanchetti A, Anders RJ. Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial. JAMA. 2003 Apr 23-30; 289(16):2073-82.
  View in: PubMed
 
156. Mansoor GA, Suri R, White WB. Determinants of left atrial size in patients with newly diagnosed untreated hypertension. Blood Press Monit. 2003 Feb; 8(1):3-7.
  View in: PubMed
 
157. White WB. Clinical trial experience around the globe: focus on calcium-channel blockers. Clin Cardiol. 2003 Feb; 26(2 Suppl 2):II7-11.
  View in: PubMed
 
158. Messerli FH, White WB, Staessen JA. If only cardiologists did properly measure blood pressure. Blood pressure recordings in daily practice and clinical trials. J Am Coll Cardiol. 2002 Dec 18; 40(12):2201-3.
  View in: PubMed
 
159. White WB. Systolic versus diastolic blood pressure versus pulse pressure. Curr Cardiol Rep. 2002 Nov; 4(6):463-7.
  View in: PubMed
 
160. Whelton A, White WB, Bello AE, Puma JA, Fort JG. Effects of celecoxib and rofecoxib on blood pressure and edema in patients > or =65 years of age with systemic hypertension and osteoarthritis. Am J Cardiol. 2002 Nov 1; 90(9):959-63.
  View in: PubMed
 
161. Herbst T, Anis-Anwar Y, Giacco S, White WB. Evaluation of the overall system precision of the Welch-Allyn transtelephonic home blood pressure monitor in adults with Parkinson's disease. Blood Press Monit. 2002 Oct; 7(5):285-8.
  View in: PubMed
 
162. White WB, Sica DA, Calhoun D, Mansoor GA, Anders RJ. Preventing increases in early-morning blood pressure, heart rate, and the rate-pressure product with controlled onset extended release verapamil at bedtime versus enalapril, losartan, and placebo on arising. Am Heart J. 2002 Oct; 144(4):657-65.
  View in: PubMed
 
163. Peixoto AJ, White WB. Ambulatory blood pressure monitoring in chronic renal disease: technical aspects and clinical relevance. Curr Opin Nephrol Hypertens. 2002 Sep; 11(5):507-16.
  View in: PubMed
 
164. White WB. Cyclooxygenase-2 inhibitors and cardiovascular thromboembolic events. J Am Coll Cardiol. 2002 Aug 7; 40(3):577-8; author reply 578.
  View in: PubMed
 
165. White WB, LaRocca GM. Chronopharmacology of cardiovascular therapy. Blood Press Monit. 2002 Aug; 7(4):199-207.
  View in: PubMed
 
166. White WB. Comparative effects of telmisartan in the treatment of hypertension. J Clin Hypertens (Greenwich). 2002 Jul-Aug; 4(4 Suppl 1):20-5.
  View in: PubMed
 
167. Simon LS, Smolen JS, Abramson SB, Appel G, Bombardier C, Brater DC, Breedveld FC, Brune K, Burmester GR, Crofford LJ, Dougados M, DuBois RN, Fitzgerald GA, Frishman W, García Rodríguez LA, Hochberg MC, Kalden JR, Laine L, Langman MJ, Prescott SM, van de Putte LB, Whelton A, White WB, Willaims GH. Controversies in COX-2 selective inhibition. J Rheumatol. 2002 Jul; 29(7):1501-10.
  View in: PubMed
 
168. White WB, Kent J, Taylor A, Verburg KM, Lefkowith JB, Whelton A. Effects of celecoxib on ambulatory blood pressure in hypertensive patients on ACE inhibitors. Hypertension. 2002 Apr; 39(4):929-34.
  View in: PubMed
 
169. White WB, Faich G, Whelton A, Maurath C, Ridge NJ, Verburg KM, Geis GS, Lefkowith JB. Comparison of thromboembolic events in patients treated with celecoxib, a cyclooxygenase-2 specific inhibitor, versus ibuprofen or diclofenac. Am J Cardiol. 2002 Feb 15; 89(4):425-30.
  View in: PubMed
 
170. White WB. Clinical utility of ambulatory blood pressure: perspectives for national insurance coverage. Blood Press Monit. 2002 Feb; 7(1):27-31.
  View in: PubMed
 
171. Verdecchia P, Staessen JA, White WB, Imai Y, O'Brien ET. Properly defining white coat hypertension. Eur Heart J. 2002 Jan; 23(2):106-9.
  View in: PubMed
 
172. White WB, Whelton A. Cardiovascular events and COX-2 inhibitors. JAMA. 2001 Dec 12; 286(22):2811-2.
  View in: PubMed
 
173. White WB, Johnson MF, Black HR, Elliott WJ, Sica DA. Gender and age effects on the ambulatory blood pressure and heart rate responses to antihypertensive therapy. Am J Hypertens. 2001 Dec; 14(12):1239-47.
  View in: PubMed
 
174. White WB, Anwar YA, Mansoor GA, Sica DA. Evaluation of the 24-hour blood pressure effects of eprosartan in patients with systemic hypertension. Am J Hypertens. 2001 Dec; 14(12):1248-55.
  View in: PubMed
 
175. White WB, Johnson MF, Anders RJ, Elliott WJ, Black HR. Safety of controlled-onset extended-release verapamil in middle-aged and older patients with hypertension and coronary artery disease. Am Heart J. 2001 Dec; 142(6):1010-5.
  View in: PubMed
 
176. Oncken CA, White WB, Cooney JL, Van Kirk JR, Ahluwalia JS, Giacco S. Impact of smoking cessation on ambulatory blood pressure and heart rate in postmenopausal women. Am J Hypertens. 2001 Sep; 14(9 Pt 1):942-9.
  View in: PubMed
 
177. Vidt DG, White WB, Ridley E, Rahman M, Harris S, Vendetti J, Michelson EL, Wang R. A forced titration study of antihypertensive efficacy of candesartan cilexetil in comparison to losartan: CLAIM Study II. J Hum Hypertens. 2001 Jul; 15(7):475-80.
  View in: PubMed
 
178. White WB. The systolic blood pressure versus pulse pressure controversy. Am J Cardiol. 2001 Jun 1; 87(11):1278-81.
  View in: PubMed
 
179. White WB. Cardiovascular risk and therapeutic intervention for the early morning surge in blood pressure and heart rate. Blood Press Monit. 2001 Apr; 6(2):63-72.
  View in: PubMed
 
180. White WB, Anwar YA. Evaluation of the overall efficacy of the Omron office digital blood pressure HEM-907 monitor in adults. Blood Press Monit. 2001 Apr; 6(2):107-10.
  View in: PubMed
 
181. White WB, Elliott WJ, Johnson MF, Black HR. Chronotherapeutic delivery of verapamil in obese versus non-obese patients with essential hypertension. J Hum Hypertens. 2001 Feb; 15(2):135-41.
  View in: PubMed
 
182. Peixoto AJ, Santos SF, Mendes RB, Crowley ST, Maldonado R, Orias M, Mansoor GA, White WB. Reproducibility of ambulatory blood pressure monitoring in hemodialysis patients. Am J Kidney Dis. 2000 Nov; 36(5):983-90.
  View in: PubMed
 
183. Glasser SP, Frishman W, White WB, Stone P, Johnson MF. Circadian heart rate response to chronotherapy versus conventional therapy in patients with hypertension and myocardial ischemia. Clin Cardiol. 2000 Jul; 23(7):524-9.
  View in: PubMed
 
184. Mansoor GA, White WB, McCabe EJ, Giacco S. The relationship of electronically monitored physical activity to blood pressure, heart rate, and the circadian blood pressure profile. Am J Hypertens. 2000 Mar; 13(3):262-7.
  View in: PubMed
 
185. White WB, Prisant LM, Wright JT. Management of patients with hypertension and diabetes mellitus: advances in the evidence for intensive treatment. Am J Med. 2000 Feb 15; 108(3):238-45.
  View in: PubMed
 
186. Mansoor GA, Tendler BE, Anwar YA, Uwaifo G, White WB. Coexistence of atherosclerotic renal artery stenosis with primary hyperaldosteronism. J Hum Hypertens. 2000 Feb; 14(2):151-3.
  View in: PubMed
 
187. White WB. Benefits of antihypertensive therapy in older patients with hypertension. Arch Intern Med. 2000 Jan 24; 160(2):149-50.
  View in: PubMed
 
188. White WB. Ambulatory blood pressure monitoring: dippers compared with non-dippers. Blood Press Monit. 2000; 5 Suppl 1:S17-23.
  View in: PubMed
 
189. White WB, Sica DA. Vascular disease and the renin-angiotensin system in the patient with hypertension. Blood Press Monit. 2000; 5 Suppl 2:S1.
  View in: PubMed
 
190. White WB. The evaluation of antihypertensive therapy using 24-h ambulatory monitoring technology. Blood Press Monit. 2000; 5 Suppl 2:S13-7.
  View in: PubMed
 
191. Hollenberg NK, Izzo JL, Sica DA, White WB, Mansoor GA. Vascular disease and the renin-angiotensin system in the patient with hypertension: panel discussion and questions from the audience. Blood Press Monit. 2000; 5 Suppl 2:S27-9.
  View in: PubMed
 
192. White WB. Cardiovascular risk and ambulatory blood pressure. Curr Hypertens Rep. 1999 Dec; 1(6):509-11.
  View in: PubMed
 
193. White WB, Asmar R, Imai Y, Mansoor GA, Padfield P, Thijs L, Waeber B. Task force VI: Self-monitoring of the blood pressure. Blood Press Monit. 1999 Dec; 4(6):343-51.
  View in: PubMed
 
194. Mansoor GA, White WB. Is white-coat hypertension innocent or detrimental? Blood Press Monit. 1999 Oct; 4(5):241-7.
  View in: PubMed
 
195. White WB, Mansoor GA, Pickering TG, Vidt DG, Hutchinson HG, Johnson RB, Noveck R. Differential effects of morning and evening dosing of nisoldipine ER on circadian blood pressure and heart rate. Am J Hypertens. 1999 Aug; 12(8 Pt 1):806-14.
  View in: PubMed
 
196. White WB. Ambulatory blood pressure as a predictor of target organ disease and outcome in the hypertensive patient. Blood Press Monit. 1999 Jun-Aug; 4(3-4):181-4.
  View in: PubMed
 
197. Gradman AH, Gray J, Maggiacomo F, Punzi H, White WB. Assessment of once-daily eprosartan, an angiotensin II antagonist, in patients with systemic hypertension. Eprosartan Study Group. Clin Ther. 1999 Mar; 21(3):442-53.
  View in: PubMed
 
198. White WB. Heart rate and the rate-pressure product as determinants of cardiovascular risk in patients with hypertension. Am J Hypertens. 1999 Feb; 12(2 Pt 2):50S-55S.
  View in: PubMed
 
199. White WB, Johnson MF, Black HR, Fakouhi TD. Effects of the chronotherapeutic delivery of verapamil on circadian blood pressure in African-American patients with hypertension. Ethn Dis. 1999; 9(3):341-9.
  View in: PubMed
 
200. Dias VC, Tendler B, Oparil S, Reilly PA, Snarr P, White WB. Clinical experience with transdermal clonidine in African-American and Hispanic-American patients with hypertension: evaluation from a 12-week prospective, open-label clinical trial in community-based clinics. Am J Ther. 1999 Jan; 6(1):19-24.
  View in: PubMed
 
201. White WB. Circadian variation of blood pressure and the assessment of antihypertensive therapy. Blood Press Monit. 1999; 4 Suppl 1:S3-6.
  View in: PubMed
 
202. White WB. How well does ambulatory blood pressure predict target-organ disease and clinical outcome in patients with hypertension? Blood Press Monit. 1999; 4 Suppl 2:S17-21.
  View in: PubMed
 
203. Reif M, White WB, Fagan TC, Oparil S, Flanagan TL, Edwards DT, Cushing DJ, Michelson EL. Effects of candesartan cilexetil in patients with systemic hypertension. Candesartan Cilexetil Study Investigators. Am J Cardiol. 1998 Oct 15; 82(8):961-5.
  View in: PubMed
 
204. Peixoto AJ, Mansoor GA, White WB. [Clinical value of ambulatory monitoring of blood pressure]. Rev Assoc Med Bras. 1998 Oct-Dec; 44(4):325-30.
  View in: PubMed
 
205. Black HR, Elliott WJ, Neaton JD, Grandits G, Grambsch P, Grimm RH, Hansson L, Lacoucière Y, Muller J, Sleight P, Weber MA, White WB, Williams G, Wittes J, Zanchetti A, Fakouhi TD. Rationale and design for the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) Trial. Control Clin Trials. 1998 Aug; 19(4):370-90.
  View in: PubMed
 
206. Anwar YA, White WB. Chronotherapeutics for cardiovascular disease. Drugs. 1998 May; 55(5):631-43.
  View in: PubMed
 
207. Mansoor GA, White WB. Circadian blood pressure variation in hypertensive patients with primary hyperaldosteronism. Hypertension. 1998 Mar; 31(3):843-7.
  View in: PubMed
 
208. White WB, Black HR, Weber MA, Elliott WJ, Bryzinski B, Fakouhi TD. Comparison of effects of controlled onset extended release verapamil at bedtime and nifedipine gastrointestinal therapeutic system on arising on early morning blood pressure, heart rate, and the heart rate-blood pressure product. Am J Cardiol. 1998 Feb 15; 81(4):424-31.
  View in: PubMed
 
209. Mansoor GA, White WB. Ambulatory blood pressure monitoring is a useful clinical tool in nephrology. Am J Kidney Dis. 1997 Nov; 30(5):591-605.
  View in: PubMed
 
210. White WB. Comments on the study of Zannad et al. Monitoring to evaluate antihypertensive therapy. Am J Hypertens. 1997 Oct; 10(10 Pt 1):1190.
  View in: PubMed
 
211. White WB, Mehrotra DV, Black HR, Fakouhi TD. Effects of controlled-onset extended-release verapamil on nocturnal blood pressure (dippers versus nondippers). COER-Verapamil Study Group. Am J Cardiol. 1997 Aug 15; 80(4):469-74.
  View in: PubMed
 
212. Anwar YA, Sullivan ED, Chen HH, White WB. Abrupt, severe hypertension associated with dissection of a renal artery during selective catheterization. J Hum Hypertens. 1997 Aug; 11(8):533-6.
  View in: PubMed
 
213. Mansoor GA, White WB. Ambulatory blood pressure monitoring in cerebrovascular and retinal vascular disease. J Stroke Cerebrovasc Dis. 1997 Jul-Aug; 6(5):313-8.
  View in: PubMed
 
214. White WB, Koch B, Stimpel M. Usefulness of moexipril and hydrochlorothiazide in moderately severe essential hypertension. Am J Ther. 1997 Apr; 4(4):123-9.
  View in: PubMed
 
215. Rehman F, Mansoor GA, White WB. "Inappropriate" physician habits in prescribing oral nifedipine capsules in hospitalized patients. Am J Hypertens. 1996 Oct; 9(10 Pt 1):1035-9.
  View in: PubMed
 
216. White WB. Relevance of the trough-to-peak ratio to the 24 h blood pressure load. Am J Hypertens. 1996 Oct; 9(10 Pt 2):91S-96S; discussion 108S-109S.
  View in: PubMed
 
217. Kass DA, Van Anden E, Becker LC, Kasper EK, White WB, Feldman AM. Dose dependence of chronic positive inotropic effect of vesnarinone in patients with congestive heart failure due to idiopathic or ischemic cardiomyopathy. Am J Cardiol. 1996 Sep 15; 78(6):652-6.
  View in: PubMed
 
218. White WB. Noctural dosing of a novel delivery system of verapamil for systemic hypertension. Am J Cardiol. 1996 May 1; 77(11):1030.
  View in: PubMed
 
219. White WB. A chronotherapeutic approach to the management of hypertension. Am J Hypertens. 1996 Apr; 9(4 Pt 3):29S-33S.
  View in: PubMed
 
220. Black HR, Smolensky MH, Johnstone MT, White WB. The emerging role of chronotherapeutics in managing hypertension. Panel discussion. Am J Hypertens. 1996 Apr; 9(4 Pt 3):34S-39S.
  View in: PubMed
 
221. Gustin G, White WB, Taylor S, Daragjati C. Clinical outcome of a mandatory formulary switch for dihydropyridine calcium channel blocker therapy at a Veteran's Administration Medical Center. Am J Hypertens. 1996 Apr; 9(4 Pt 1):312-6.
  View in: PubMed
 
222. Mansoor GA, McCabe EJ, White WB. Determinants of the white-coat effect in hypertensive subjects. J Hum Hypertens. 1996 Feb; 10(2):87-92.
  View in: PubMed
 
223. Mansoor GA, White WB, Grunnet M, Ruby ST. Intracerebral hemorrhage after carotid endarterectomy associated with ipsilateral fibrinoid necrosis: a consequence of the hyperperfusion syndrome? J Vasc Surg. 1996 Jan; 23(1):147-51.
  View in: PubMed
 
224. White WB. Ambulatory blood pressure monitoring in the evaluation of hypertension therapy. Cardiol Clin. 1995 Nov; 13(4):569-77.
  View in: PubMed
 
225. White WB, Stimpel M. Long-term safety and efficacy of moexipril alone and in combination with hydrochlorothiazide in elderly patients with hypertension. J Hum Hypertens. 1995 Nov; 9(11):879-84.
  View in: PubMed
 
226. Mansoor GA, White WB. Ambulatory blood pressure monitoring in current clinical practice and research. Curr Opin Nephrol Hypertens. 1995 Nov; 4(6):531-7.
  View in: PubMed
 
227. Mansoor GA, White WB, Friedman NC. Normal-appearing captopril MAG-3 renal scintigraphy in hemodynamically significant renal artery stenosis. A case report. Angiology. 1995 Oct; 46(10):929-35.
  View in: PubMed
 
228. White WB, Anders RJ, MacIntyre JM, Black HR, Sica DA. Nocturnal dosing of a novel delivery system of verapamil for systemic hypertension. Verapamil Study Group. Am J Cardiol. 1995 Aug 15; 76(5):375-80.
  View in: PubMed
 
229. Peixoto Filho AJ, Mansoor GA, White WB. Effects of actual versus arbitrary awake and sleep times on analyses of 24-h blood pressure. Am J Hypertens. 1995 Jul; 8(7):676-80.
  View in: PubMed
 
230. White WB, Whelton A, Fox AA, Stimpel M, Kaihlanen PM. Tricenter assessment of the efficacy of the ACE inhibitor, moexipril, by ambulatory blood pressure monitoring. J Clin Pharmacol. 1995 Mar; 35(3):233-8.
  View in: PubMed
 
231. White WB, Fox AA, Stimpel M. Long-term efficacy and safety of moexipril in the treatment of hypertension. J Hum Hypertens. 1994 Dec; 8(12):917-21.
  View in: PubMed
 
232. Mansoor GA, White WB. Olecranon bursitis associated with 24-hour ambulatory blood pressure monitoring. Am J Hypertens. 1994 Sep; 7(9 Pt 1):855-6.
  View in: PubMed
 
233. White WB, Lund-Johansen P, Weiss S, Omvik P, Indurkhya N. The relationships between casual and ambulatory blood pressure measurements and central hemodynamics in essential human hypertension. J Hypertens. 1994 Sep; 12(9):1075-81.
  View in: PubMed
 
234. Mansoor GA, White WB. Contribution of ambulatory blood pressure monitoring to the design and analysis of antihypertensive therapy trials. J Cardiovasc Risk. 1994 Aug; 1(2):136-42.
  View in: PubMed
 
235. White WB, Susser W, James GD, Marra L, McCabe EJ, Pickering TG, Streeten DH. Multicenter assessment of the QuietTrak ambulatory blood pressure recorder according to the 1992 AAMI guidelines. Am J Hypertens. 1994 Jun; 7(6):509-14.
  View in: PubMed
 
236. Mansoor GA, McCabe EJ, White WB. Long-term reproducibility of ambulatory blood pressure. J Hypertens. 1994 Jun; 12(6):703-8.
  View in: PubMed
 
237. Esayag-Tendler B, Yamase H, Ramsby G, White WB. Accelerated hypertension with encephalopathy due to an isolated dissection of a renal artery branch vessel. Am J Kidney Dis. 1994 Jun; 23(6):869-73.
  View in: PubMed
 
238. Sheps SG, Clement DL, Pickering TG, Krakoff LR, White WB, Messerli FH, Weber MA, Perloff D. Ambulatory blood pressure monitoring. Hypertensive Diseases Committee, American College of Cardiology. J Am Coll Cardiol. 1994 May; 23(6):1511-3.
  View in: PubMed
 
239. White WB, Mansoor GA. Ambulatory blood pressure monitoring. Curr Opin Nephrol Hypertens. 1993 Nov; 2(6):928-34.
  View in: PubMed
 
240. Shusterman NH, Elliott WJ, White WB. Fenoldopam, but not nitroprusside, improves renal function in severely hypertensive patients with impaired renal function. Am J Med. 1993 Aug; 95(2):161-8.
  View in: PubMed
 
241. Esayag-Tendler B, White WB. Assessing hypertension management: the role of 24-hour blood pressure monitoring. Cleve Clin J Med. 1993 Jul-Aug; 60(4):278-83.
  View in: PubMed
 
242. White WB, Grin JM, McCabe EJ. Clinical usefulness of ambulatory blood pressure monitoring. Am J Hypertens. 1993 Jun; 6(6 Pt 2):225S-228S.
  View in: PubMed
 
243. White WB, Lund-Johansen P, Omvik P. Twenty-four-hour blood pressure load as a surrogate end-point in assessing antihypertensive therapy. J Hypertens Suppl. 1993 Jun; 11(4):S75-80.
  View in: PubMed
 
244. Grin JM, McCabe EJ, White WB. Management of hypertension after ambulatory blood pressure monitoring. Ann Intern Med. 1993 Jun 1; 118(11):833-7.
  View in: PubMed
 
245. White WB, Berson AS, Robbins C, Jamieson MJ, Prisant LM, Roccella E, Sheps SG. National standard for measurement of resting and ambulatory blood pressures with automated sphygmomanometers. Hypertension. 1993 Apr; 21(4):504-9.
  View in: PubMed
 
246. Ruby ST, Burch A, White WB. Unilateral renal artery stenosis seen initially as severe and symptomatic hypokalemia. Pathophysiologic assessment and effects of surgical revascularization. Arch Surg. 1993 Mar; 128(3):346-8.
  View in: PubMed
 
247. Halaban R, Rubin JS, Funasaka Y, Cobb M, Boulton T, Faletto D, Rosen E, Chan A, Yoko K, White W, et al. Met and hepatocyte growth factor/scatter factor signal transduction in normal melanocytes and melanoma cells. Oncogene. 1992 Nov; 7(11):2195-206.
  View in: PubMed
 
248. White WB. Accuracy and analysis of ambulatory blood pressure monitoring data. Clin Cardiol. 1992 Oct; 15(5 Suppl 2):II10-3.
  View in: PubMed
 
249. White WB, Malchoff C. Diurnal blood pressure variability in mineralocorticoid excess syndrome. Am J Hypertens. 1992 Jun; 5(6 Pt 1):414-8.
  View in: PubMed
 
250. White WB. The role of ambulatory monitoring of the blood pressure for assessment of antihypertensive agents. J Clin Pharmacol. 1992 Jun; 32(6):524-8.
  View in: PubMed
 
251. White WB. Utilizing ambulatory blood pressure recordings to evaluate antihypertensive drug therapy. Am J Cardiol. 1992 Apr 30; 69(13):8E-12E.
  View in: PubMed
 
252. White WB. Diurnal blood pressure and blood pressure variability in diabetic normotensive and hypertensive subjects. J Hypertens Suppl. 1992 Apr; 10(1):S35-41.
  View in: PubMed
 
253. White WB. Impact of the daily blood pressure load on the development of hypertensive heart disease. Cardiology. 1992; 81(4-5):299-306.
  View in: PubMed
 
254. White WB. Ambulatory blood pressure monitoring during exercise and physical activity. J Hypertens Suppl. 1991 Dec; 9(8):S22-4.
  View in: PubMed
 
255. White WB. Blood pressure load and target organ effects in patients with essential hypertension. J Hypertens Suppl. 1991 Dec; 9(8):S39-41.
  View in: PubMed
 
256. White WB, Pickering TG, Morganroth J, James GD, McCabe EJ, Moucha O, Hunter H. A multicenter evaluation of the A&D TM-2420 ambulatory blood pressure recorder. Am J Hypertens. 1991 Nov; 4(11):890-6.
  View in: PubMed
 
257. White WB. Assessment of ambulatory blood pressure recorders: accuracy and clinical performance. Clin Invest Med. 1991 Jun; 14(3):202-11.
  View in: PubMed
 
258. White WB. Ambulatory blood pressure and target organ involvement in hypertension. Clin Invest Med. 1991 Jun; 14(3):224-30.
  View in: PubMed
 
259. White WB. Analysis of ambulatory blood pressure data in antihypertensive drug trials. J Hypertens Suppl. 1991 Jan; 9(1):S27-32.
  View in: PubMed
 
260. White WB. Predicting hypertensive heart disease via non-invasive methodology: relationship between ambulatory blood pressure and cardiac indices derived by echocardiography and radionuclide ventriculography. J Hypertens Suppl. 1990 Dec; 8(6):S113-8.
  View in: PubMed
 
261. Mallonee DH, White WB, Hylemon PB. Cloning and sequencing of a bile acid-inducible operon from Eubacterium sp. strain VPI 12708. J Bacteriol. 1990 Dec; 172(12):7011-9.
  View in: PubMed
 
262. Gopal-Srivastava R, Mallonee DH, White WB, Hylemon PB. Multiple copies of a bile acid-inducible gene in Eubacterium sp. strain VPI 12708. J Bacteriol. 1990 Aug; 172(8):4420-6.
  View in: PubMed
 
263. White WB. The assessment of portable, non-invasive blood pressure recorders. J Hypertens. 1990 Jul; 8(7):591-3.
  View in: PubMed
 
264. Lund-Johansen P, White WB. Central hemodynamics and 24-hour blood pressure in obstructive sleep apnea syndrome: effects of corrective surgery. Am J Med. 1990 Jun; 88(6):678-82.
  View in: PubMed
 
265. White WB, Lund-Johansen P, Omvik P. Assessment of four ambulatory blood pressure monitors and measurements by clinicians versus intraarterial blood pressure at rest and during exercise. Am J Cardiol. 1990 Jan 1; 65(1):60-6.
  View in: PubMed
 
266. White WB, Lund-Johansen P, McCabe EJ, Omvik P. Clinical evaluation of the Accutracker II ambulatory blood pressure monitor: assessment of performance in two countries and comparison with sphygmomanometry and intra-arterial blood pressure at rest and during exercise. J Hypertens. 1989 Dec; 7(12):967-75.
  View in: PubMed
 
267. White WB, Schulman P, Dey HM, Katz AM. Rapid left ventricular filling is more dependent on age and twenty-four-hour blood pressure than on cardiac size. J Hypertens Suppl. 1989 Dec; 7(6):S102-3.
  View in: PubMed
 
268. White WB, Dey HM, Schulman P. Assessment of the daily blood pressure load as a determinant of cardiac function in patients with mild-to-moderate hypertension. Am Heart J. 1989 Oct; 118(4):782-95.
  View in: PubMed
 
269. White WB, Schulman P, Dey HM, Katz AM. Effects of age and 24-hour ambulatory blood pressure on rapid left ventricular filling. Am J Cardiol. 1989 Jun 1; 63(18):1343-7.
  View in: PubMed
 
270. White WB. Methods of blood pressure determination to assess antihypertensive agents: are casual measurements enough? Clin Pharmacol Ther. 1989 Jun; 45(6):581-6.
  View in: PubMed
 
271. White WB, Lund-Johansen P, McCabe EJ. Clinical evaluation of the Colin ABPM 630 at rest and during exercise: an ambulatory blood pressure monitor with gas-powered cuff inflation. J Hypertens. 1989 Jun; 7(6):477-83.
  View in: PubMed
 
272. Bednarczyk EM, White WB, Munger MA, Gonzalez FM, Panacek EA, Weed SG, Rutherford WF, Nara AR, Green JA. Comparative acute blood pressure reduction from intravenous fenoldopam mesylate versus sodium nitroprusside in severe systemic hypertension. Am J Cardiol. 1989 Apr 15; 63(13):993-6.
  View in: PubMed
 
273. White WB, Halley SE. Comparative renal effects of intravenous administration of fenoldopam mesylate and sodium nitroprusside in patients with severe hypertension. Arch Intern Med. 1989 Apr; 149(4):870-4.
  View in: PubMed
 
274. White WB, Schulman P, McCabe EJ, Dey HM. Average daily blood pressure, not office blood pressure, determines cardiac function in patients with hypertension. JAMA. 1989 Feb 10; 261(6):873-7.
  View in: PubMed
 
275. White WB, Schulman P, Karimeddini MK, Smith VE. Regression of left ventricular mass is accompanied by improvement in rapid left ventricular filling following antihypertensive therapy with metoprolol. Am Heart J. 1989 Jan; 117(1):145-50.
  View in: PubMed
 
276. White WB, Yeh SC, Krol GJ. Nitrendipine in human plasma and breast milk. Eur J Clin Pharmacol. 1989; 36(5):531-4.
  View in: PubMed
 
277. White WB, Morganroth J. Usefulness of ambulatory monitoring of blood pressure in assessing antihypertensive therapy. Am J Cardiol. 1989 Jan 1; 63(1):94-8.
  View in: PubMed
 
278. Halley SE, White WB, Ramsby GR, Voytovich AE. Renovascular hypertension in moyamoya syndrome. Therapeutic response to percutaneous transluminal angioplasty. Am J Hypertens. 1988 Oct; 1(4 Pt 1):348-52.
  View in: PubMed
 
279. White WB, Franklund CV, Coleman JP, Hylemon PB. Evidence for a multigene family involved in bile acid 7-dehydroxylation in Eubacterium sp. strain VPI 12708. J Bacteriol. 1988 Oct; 170(10):4555-61.
  View in: PubMed
 
280. White WB, Aydelotte ME. Clinical experience with labetalol and enalapril in combination in patients with severe essential and renovascular hypertension. Am J Med Sci. 1988 Sep; 296(3):187-91.
  View in: PubMed
 
281. White WB, McCabe EJ, Hager WD, Schulman P. The effects of the long-acting angiotensin-converting enzyme inhibitor cilazapril on casual, exercise, and ambulatory blood pressure. Clin Pharmacol Ther. 1988 Aug; 44(2):173-8.
  View in: PubMed
 
282. White WB, Rodman MD. The effects of cardiovascular drugs on exercise performance. J Cardiovasc Nurs. 1988 Aug; 2(4):30-9.
  View in: PubMed
 
283. Coleman JP, White WB, Lijewski M, Hylemon PB. Nucleotide sequence and regulation of a gene involved in bile acid 7-dehydroxylation by Eubacterium sp. strain VPI 12708. J Bacteriol. 1988 May; 170(5):2070-7.
  View in: PubMed
 
284. White WB, Radford MJ, Gonzalez FM, Weed SG, McCabe EJ, Katz AM. Selective dopamine-1 agonist therapy in severe hypertension: effects of intravenous fenoldopam. J Am Coll Cardiol. 1988 May; 11(5):1118-23.
  View in: PubMed
 
285. White WB, Coleman JP, Hylemon PB. Molecular cloning of a gene encoding a 45,000-dalton polypeptide associated with bile acid 7-dehydroxylation in Eubacterium sp. strain VPI 12708. J Bacteriol. 1988 Feb; 170(2):611-6.
  View in: PubMed
 
286. O'Meara J, White WB. Ejaculatory failure and urinary dysfunction secondary to labetalol. J Urol. 1988 Feb; 139(2):371-2.
  View in: PubMed
 
287. White WB, Schulman P, McCabe EJ, Nardone MB. Clinical validation of the accutracker, a novel ambulatory blood pressure monitor using R-wave gating for Korotkoff sounds. J Clin Hypertens. 1987 Dec; 3(4):500-9.
  View in: PubMed
 
288. White WB, Baker LH. Ambulatory blood pressure monitoring in patients with panic disorder. Arch Intern Med. 1987 Nov; 147(11):1973-5.
  View in: PubMed
 
289. White WB, Pandit RS. The antihypertensive agents: clinical pharmacology and therapeutic monitoring. Clin Lab Med. 1987 Sep; 7(3):607-23.
  View in: PubMed
 
290. White WB, Desbonnet CR, Ballow M. Immunoregulatory effects of intravenous immune serum globulin therapy in common variable hypogammaglobulinemia. Am J Med. 1987 Sep; 83(3):431-6.
  View in: PubMed
 
291. White WB. Orthostatic hypotension and pernicious anemia. JAMA. 1987 Jun 19; 257(23):3231.
  View in: PubMed
 
292. Feder HM, White WB. Herpes simplex virus infections. N Engl J Med. 1987 Mar 19; 316(12):754-5.
  View in: PubMed
 
293. Smith VE, White WB, Karimeddini MK. Echocardiographic assessment of left ventricular diastolic performance in hypertensive subjects. Correlation with changes in left ventricular mass. Hypertension. 1987 Feb; 9(2 Pt 2):II81-4.
  View in: PubMed
 
294. Drayer JI, Hall WD, Smith VE, Weber MA, Wollam GL, White WB. Effect of the calcium channel blocker nitrendipine on left ventricular mass in patients with hypertension. Clin Pharmacol Ther. 1986 Dec; 40(6):679-85.
  View in: PubMed
 
295. Smith VE, White WB, Meeran MK, Karimeddini MK. Improved left ventricular filling accompanies reduced left ventricular mass during therapy of essential hypertension. J Am Coll Cardiol. 1986 Dec; 8(6):1449-54.
  View in: PubMed
 
296. White WB, Andreoli JW. Severe, accelerated postpartum hypertension associated with hyperthyroxinaemia. Case report. Br J Obstet Gynaecol. 1986 Dec; 93(12):1297-9.
  View in: PubMed
 
297. White WB. Assessment of patients with office hypertension by 24-hour noninvasive ambulatory blood pressure monitoring. Arch Intern Med. 1986 Nov; 146(11):2196-9.
  View in: PubMed
 
298. White WB. Hypotension with postural syncope secondary to the combination of chlorpromazine and captopril. Arch Intern Med. 1986 Sep; 146(9):1833-4.
  View in: PubMed
 
299. White WB, Schulman P, McCabe EJ. Psoriasiform cutaneous eruptions induced by cetamolol hydrochloride. Arch Dermatol. 1986 Aug; 122(8):857-8.
  View in: PubMed
 
300. White WB, Schulman P, McCabe EJ, Hager WD. Effects of chronic cetamolol therapy on resting, ambulatory, and exercise blood pressure and heart rate. Clin Pharmacol Ther. 1986 Jun; 39(6):664-8.
  View in: PubMed
 
301. White WB, Baker LH. Episodic hypertension secondary to panic disorder. Arch Intern Med. 1986 Jun; 146(6):1129-30.
  View in: PubMed
 
302. White WB, Ryan RW, Staley DD, Ballow M. Passive transfer of antibodies to human T-cell lymphotropic virus type III in patients receiving high-dose intravenous immunoglobulin. JAMA. 1986 May 16; 255(19):2602-3.
  View in: PubMed
 
303. White WB, Viadero JJ, Lane TJ, Podesla S. Effects of combination therapy with captopril and nifedipine in severe or resistant hypertension. Clin Pharmacol Ther. 1986 Jan; 39(1):43-8.
  View in: PubMed
 
304. White WB, Gilbert JC. Transdermal clonidine in a patient with resistant hypertension and malabsorption. N Engl J Med. 1985 Nov 28; 313(22):1418.
  View in: PubMed
 
305. White WB. Aggravated CNS depression with urinary retention secondary to baclofen administration. Arch Intern Med. 1985 Sep; 145(9):1717-8.
  View in: PubMed
 
306. Abrams JH, Schulman P, White WB. Successful treatment of a monoamine oxidase inhibitor-tyramine hypertensive emergency with intravenous labetalol. N Engl J Med. 1985 Jul 4; 313(1):52.
  View in: PubMed
 
307. White WB, Smith VE, McCabe EJ, Meeran MK. Effects of chronic nitrendipine on casual (office) and 24-hour ambulatory blood pressure. Clin Pharmacol Ther. 1985 Jul; 38(1):60-4.
  View in: PubMed
 
308. Smith VE, Schulman P, Karimeddini MK, White WB, Meeran MK, Katz AM. Rapid ventricular filling in left ventricular hypertrophy: II. Pathologic hypertrophy. J Am Coll Cardiol. 1985 Apr; 5(4):869-74.
  View in: PubMed
 
309. White WB, Andreoli JW, Cohn RD. Alpha-methyldopa disposition in mothers with hypertension and in their breast-fed infants. Clin Pharmacol Ther. 1985 Apr; 37(4):387-90.
  View in: PubMed
 
310. White WB. The Rumpel-Leede sign associated with a noninvasive ambulatory blood pressure monitor. JAMA. 1985 Mar 22-29; 253(12):1724.
  View in: PubMed
 
311. White WB, Shornick JK, Grant-Kels JM, Ballow M. Erythroderma with spongiotic dermatitis. Association with common variable hypogammaglobulinemia. Am J Med. 1985 Mar; 78(3):523-8.
  View in: PubMed
 
312. White WB, Ballow M. Modulation of suppressor-cell activity by cimetidine in patients with common variable hypogammaglobulinemia. N Engl J Med. 1985 Jan 24; 312(4):198-202.
  View in: PubMed
 
313. Wong SH, White WB, Fernandes R, Holden R, Lin FC, Narayanan S. Assessment of blood collection systems for the high performance liquid chromatography measurement of propranolol. Ther Drug Monit. 1985; 7(3):358-63.
  View in: PubMed
 
314. White WB. Beta blockers with intrinsic sympathomimetic activity. Am Fam Physician. 1985 Jan; 31(1):115-8.
  View in: PubMed
 
315. Weiser GA, Forouhar FA, White WB. Hydralazine hoarseness. A new appearance of drug-induced systemic lupus erythematosus. Arch Intern Med. 1984 Nov; 144(11):2271-2.
  View in: PubMed
 
316. Rosenfeld AS, White WB. Allergic contact dermatitis secondary to transdermal nitroglycerin. Am Heart J. 1984 Oct; 108(4 Pt 1):1061-2.
  View in: PubMed
 
317. White WB, Grant-Kels JM. Transmission of herpes simplex virus type 1 infection in rugby players. JAMA. 1984 Jul 27; 252(4):533-5.
  View in: PubMed
 
318. White WB. Management of hypertension during lactation. Hypertension. 1984 May-Jun; 6(3):297-300.
  View in: PubMed
 
319. White WB, Hanna M, Stewart JA. Systemic herpes simplex virus type 2 infection. Proctitis, urinary retention, arthralgias, and meningitis in the absence of primary mucocutaneous lesions. Arch Intern Med. 1984 Apr; 144(4):826-7.
  View in: PubMed
 
320. White WB, Andreoli JW, Wong SH, Cohn RD. Atenolol in human plasma and breast milk. Obstet Gynecol. 1984 Mar; 63(3 Suppl):42S-44S.
  View in: PubMed
 
321. White WB, Andreoli JA. Painless postpartum thyroiditis seen initially as severe hypertension. Am J Obstet Gynecol. 1984 Feb 1; 148(3):346-7.
  View in: PubMed
 
322. Viadero JJ, Wong SH, White WB. Acute psychotic behavior associated with atenolol. Am J Psychiatry. 1983 Oct; 140(10):1382.
  View in: PubMed
 
323. White WB, DeMartino SA, Yoshida T. Severe delayed inflammatory reactions from injected insulin. Association with cell-mediated immunity. Am J Med. 1983 May; 74(5):909-14.
  View in: PubMed
 
324. White WB, Riotte K. Propranolol and white rabbits. N Engl J Med. 1982 Aug 26; 307(9):558-9.
  View in: PubMed
 
325. White WB, Reik L, Cutlip DE. Pernicious anemia seen initially as orthostatic hypotension. Arch Intern Med. 1981 Oct; 141(11):1543-4.
  View in: PubMed
 
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile contact profiles@uchc.edu.
 
Keyword
Last Name
Institution
    
 
 
 
Co-Authors  
Baker, William
Marfatia, Ravi
Pearlson, Godfrey
Wakefield, Dorothy
Wolfson, Leslie
See all (13) people
Physical Neighbors  
Kenny, Anne
Mirza, Faryal
Caines, Laurie
Cherniack, Martin
Hegde, Upendra
 
A-Z Index UConn Health Center Disclaimer, Privacy Notice & Copyright Maps & Directions Contact Us © University of Connecticut Health Center